Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS)
Status:
Unknown status
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of DN-101 (calcitriol) in
patients with myelodysplastic syndrome who are dependent on repeat blood transfusions.